Background and Objectives: There is a lack of information on
therapies recommended by naturopathic doctors (NDs) for lung and
gastroesophageal cancer care. Study objectives were to: (1) identify the most
common interventions considered for use by NDs; (2) identify interventions NDs
recommend to support key therapeutic goals; and (3) identify potential
contraindications between integrative and conventional therapies.
Methods: Oncology Association of Naturopathic Physicians
(OncANP) members (n = 351) were invited to complete an electronic survey.
Respondents provided information on interventions considered for thoracic cancer
pre- and postoperatively across 4 therapeutic domains (supplemental natural
health products, physical, mental/emotional, and nutritional), therapeutic
goals, and contraindications. This survey was part of the development of the
Thoracic Perioperative Integrative Surgical Evaluation trial.
Results: Forty-four NDs completed the survey (12.5% response
rate), all of whom were trained at accredited colleges in North America and the
majority of whom were Fellows of the American Board of Naturopathic Oncology
(FABNO) (56.8%). NDs identified significantly more interventions in the
postoperative compared to preoperative setting. The most frequently identified
interventions included modified citrus pectin, arnica, omega-3 fatty acids,
vitamin D, probiotics, exercise, acupuncture, meditation, stress reduction, low
glycemic index diet, and Mediterranean diet. Potential contraindications with
conventional treatment (surgery, chemotherapy, radiotherapy) differed across
natural health products. Conclusions: These findings highlight
naturopathic interventions with a high level of use in thoracic cancer care,
describe and characterize therapeutic goals and the interventions used to
achieve these goals, and provide insight on how practice changes relative to
conventional cancer treatment phase.